Publications by authors named "Simona Scodes"

Claim this Profile
T
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer.
Giuseppe Bronte, Maurizio Puccetti, Elisabetta Petracci, Lorenza Landi, Paola Cravero, Simona Scodes

Front Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.
Alessio Cortellini, Marcello Tiseo, Giuseppe L Banna, Federico Cappuzzo, Joachim G J V Aerts, Simona Scodes

Cancer Immunol Immunother· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes.
Alessio Cortellini, Alex Friedlaender, Giuseppe L Banna, Giampiero Porzio, Melissa Bersanelli, Simona Scodes

Clin Lung Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation.
Alessio Cortellini, Biagio Ricciuti, Marcello Tiseo, Emilio Bria, Giuseppe L Banna, Simona Scodes

J Immunother Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the appropriate treatment for different EGFR mutations in non-small cell lung cancer patients.
Simona Scodes, Federico Cappuzzo

Expert Rev Respir Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis